Status:
COMPLETED
The Effectiveness of SMS in Improving Antiretroviral Medication Adherence Among Adolescents Living With HIV in Nigeria
Lead Sponsor:
Dr. Olumide ABIODUN
Conditions:
HIV Infections
Eligibility:
All Genders
15-19 years
Phase:
NA
Brief Summary
The non-maintenance of ART adherence is a major barrier to the achievement of optimal treatment outcomes among adolescents living with HIV. ART adherence is a challenge among adolescents living with H...
Detailed Description
BACKGROUND In Nigeria, approximately 3.2 million people were living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) in Nigeria. Nigeria has about 196,000 adolescents ...
Eligibility Criteria
Inclusion
- HIV seropositivity
- Being on ART for at least three month
- Age 15 to 19 years as at last birthday
- Use of personal mobile phone
- Poor adherence to ART
Exclusion
- Adolescents who are too ill to require hospital admission will be excluded from the study.
Key Trial Info
Start Date :
July 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT03394391
Start Date
July 5 2018
End Date
June 30 2019
Last Update
November 15 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Lagos State University Teaching Hospital
Ikeja, Lagos, Nigeria
2
The Nigerian Institute of Medical Research
Yaba, Lagos, Nigeria
3
Federal Medical Center
Abeokuta, Ogun State, Nigeria
4
State Hospital
Ijebu Ode, Ogun State, Nigeria